Tumor-associated fibroblasts as "Trojan Horse" mediators of resistance to anti-VEGF therapy. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Tumor-associated fibroblasts as "Trojan Horse" mediators of resistance to anti-VEGF therapy.

Francia G, Emmenegger U, Kerbel RS. Tumor-associated fibroblasts as "Trojan Horse" mediators of resistance to anti-VEGF therapy. Cancer Cell. 2009 Jan 06; 15(1):3-5.

View in: PubMed

authors with profiles

Giulio Francia

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support